The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 05, 2019

Filed:

Sep. 06, 2017
Applicant:

Children's Medical Center Corporation, Boston, MA (US);

Inventors:

Zhigang He, Wellesley, MA (US);

Duo Jin, Boston, MA (US);

Fang Sun, Boston, MA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C12N 15/11 (2006.01); C07H 21/02 (2006.01); C07H 21/04 (2006.01); A61K 38/17 (2006.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01); A61K 31/4353 (2006.01); A61K 31/708 (2006.01); A61K 31/7088 (2006.01); A61K 31/713 (2006.01); A61K 33/24 (2006.01); A61K 31/444 (2006.01); A61K 31/11 (2006.01); A61K 31/196 (2006.01); A61K 31/555 (2006.01); A61K 39/395 (2006.01); A01K 67/027 (2006.01); C07K 14/47 (2006.01); C12N 9/16 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1709 (2013.01); A01K 67/0276 (2013.01); A61K 9/0085 (2013.01); A61K 31/11 (2013.01); A61K 31/196 (2013.01); A61K 31/4353 (2013.01); A61K 31/444 (2013.01); A61K 31/555 (2013.01); A61K 31/708 (2013.01); A61K 31/7088 (2013.01); A61K 31/713 (2013.01); A61K 33/24 (2013.01); A61K 39/39533 (2013.01); A61K 45/06 (2013.01); C12Y 301/03048 (2013.01); A01K 2207/30 (2013.01); A01K 2217/075 (2013.01); A01K 2217/15 (2013.01); A01K 2217/206 (2013.01); A01K 2227/105 (2013.01); A01K 2267/0356 (2013.01); C07K 14/4703 (2013.01); C12N 9/16 (2013.01);
Abstract

Disclosed herein is a method of promoting sustained survival, sustained regeneration, in a lesioned mature neuron, sustained compensatory outgrowth in a neuron, or combinations thereof. The method comprises contacting the lesioned mature neuron with an effective amount of an inhibitor of PTEN and an effective amount of an inhibitor of SOCS3 to thereby promote survival and/or regeneration and/or compensatory outgrowth of the neuron. Therapeutic methods of treatment of a subject with a neuronal lesion by administration of a therapeutically effective amount of an inhibitor of PTEN and a therapeutically effective amount of an inhibitor of SOCS3, are also disclosed, as are pharmaceutical compositions and devices for use in the methods.


Find Patent Forward Citations

Loading…